Medical Condition News

RSS

Genprex initiates Phase II clinical trial of Oncoprex for late-stage lung cancer patients

Genprex, Inc. announced today that it has enrolled the first patient in a clinical trial evaluating its lead product candidate Oncoprex in combination with erlotinib (Tarceva) for late-stage lung cancer patients.

21 May 2014

Study: Just and socially responsible layoff process is important for emotional health of workers

Researchers led by a University of North Texas Health Science Center epidemiologist found that a just and socially responsible layoff process is important for the emotional health of workers – a study that occurred during the most severe recession since the Great Depression.

21 May 2014

Nationwide Children's Hospital offers Meta-iodobenzylguanidine therapy for neuroblastoma

Meta-iodobenzylguanidine (MIBG) therapy is now offered by Hematology/Oncology/Blood and Marrow Transplant at Nationwide Children's Hospital. Patients with neuroblastoma who qualify for treatment with MIBG therapy can be treated in this new facility, with round-the-clock supervision by specially trained staff through video and audio monitoring.

21 May 2014

Research provides key insights into most aggressive form of pancreatic cancer

Mayo Clinic researchers have discovered an enzyme they say is tightly linked to how aggressive pancreatic cancer will be in a patient.

21 May 2014

New compound restores learning, memory and other symptoms of AD in mice

A molecular compound developed by Saint Louis University scientists restored learning, memory and appropriate behavior in a mouse model of Alzheimer's disease, according to findings in the May issue of the Journal of Alzheimer's Disease.

21 May 2014

Serious complications due to anesthesia during childbirth are very rare

Expectant mothers concerned about receiving an epidural, spinal or general anesthesia during childbirth can breathe a little easier. According to a study published in the June issue of Anesthesiology, the official medical journal of the American Society of Anesthesiologists, serious complications due to anesthesia during childbirth are very rare, occurring in one out of every 3,000 deliveries.

21 May 2014

Aging magnifies impact of risk factors associated with falls

Trips and falls can happen at all stages of life, but as we start to age they can become more numerous. Aging can magnify the impact of risk factors associated with falls and also brings up new and often less obvious factors that affect balance and stability.

21 May 2014

Elevated blood eosinophil levels find to be risk factor for exacerbations in asthma patients

In adults with persistent asthma, elevated blood eosinophil levels may be able to predict which individuals are at increased risk for exacerbations, according to a new study presented at the 2014 American Thoracic Society International Conference.

21 May 2014

Vitamin E-rich oils may increase incidence of asthma, says study

A large new Northwestern Medicine- study upends our understanding of vitamin E and ties the increasing consumption of supposedly healthy vitamin E-rich oils -- canola, soybean and corn - to the rising incidence of lung inflammation and, possibly, asthma.

21 May 2014

Physical activity may be able to prevent overweight women from developing heart disease

For otherwise healthy middle-aged women who are overweight or obese, physical activity may be their best option for avoiding heart disease, according to a study that followed nearly 900 women for seven years.

21 May 2014

Study: Hearing impairment linked with sleep apnea

Both high and low frequency hearing impairment have been linked with sleep apnea in a new study of nearly 14,000 individuals.

21 May 2014

Isis Pharmaceuticals starts Phase 1 clinical study of ISIS-PKKRx to treat patients with HAE

Isis Pharmaceuticals, Inc. (NASDAQ: ISIS) announced today that it initiated a Phase 1 clinical study of ISIS-PKKRx. ISIS-PKKRx is an antisense drug in development to treat patients with hereditary angioedemia (HAE).

21 May 2014

Substance from pine bark is a potential source for treating melanoma

A substance that comes from pine bark is a potential source for a new treatment of melanoma, according to Penn State College of Medicine researchers.

21 May 2014

New antibody can improve quality of life for individuals with asthma

Researchers at St. Joseph's Healthcare Hamilton and McMaster University have successfully tested an antibody that can improve the quality of life for individuals with asthma by relieving inflammation in the lungs.

21 May 2014

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

Takeda Pharmaceutical Company Limited and its wholly-owned subsidiary, Takeda Pharmaceuticals U.S.A., Inc., has announced that the United States (U.S.) Food and Drug Administration (FDA) simultaneously approved a new biologic therapy, Entyvio™ (vedolizumab), for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD).

21 May 2014

Study investigates whether use of mobile phones affects children's cognitive development

A new study launching today will investigate whether the use of mobile phones and other wireless technologies might affect children's cognitive development.

21 May 2014

Studies show mobile phones can cause allergic contact dermatitis in both children and adults

Studies have identified mobile phones and related devices as sources of metal sensitization and potential causes of allergic contact dermatitis (ACD).

21 May 2014

New cognitive test determines memory impairments due to AD and normal aging

Researchers have developed a new cognitive test that can better determine whether memory impairments are due to very mild Alzheimer's disease or the normal aging process.

21 May 2014

$15 million pledged for creation of Johns Hopkins Greenberg Bladder Cancer Institute

Baltimore-area commercial real estate developer Erwin L. Greenberg and his wife Stephanie Cooper Greenberg have pledged a $15 million gift to create the Johns Hopkins Greenberg Bladder Cancer Institute.

20 May 2014

Existing pharmaceutical drugs may offer effective therapies against MERS

A series of research articles published ahead of print in the journal Antimicrobial Agents and Chemotherapy have identified a number of existing pharmaceutical drugs and compounds under development that may offer effective therapies against Middle East Respiratory Syndrome (MERS).

20 May 2014

Medical Condition News

Genprex initiates Phase II clinical trial of Oncoprex for late-stage lung cancer patients

Study: Just and socially responsible layoff process is important for emotional health of workers

Nationwide Children's Hospital offers Meta-iodobenzylguanidine therapy for neuroblastoma

Research provides key insights into most aggressive form of pancreatic cancer

New compound restores learning, memory and other symptoms of AD in mice

Serious complications due to anesthesia during childbirth are very rare

Aging magnifies impact of risk factors associated with falls

Elevated blood eosinophil levels find to be risk factor for exacerbations in asthma patients

Vitamin E-rich oils may increase incidence of asthma, says study

Physical activity may be able to prevent overweight women from developing heart disease

Study: Hearing impairment linked with sleep apnea

Isis Pharmaceuticals starts Phase 1 clinical study of ISIS-PKKRx to treat patients with HAE

Substance from pine bark is a potential source for treating melanoma

New antibody can improve quality of life for individuals with asthma

FDA approves Takeda's Entyvio for severe active ulcerative colitis and Crohn's disease

Study investigates whether use of mobile phones affects children's cognitive development

Studies show mobile phones can cause allergic contact dermatitis in both children and adults

New cognitive test determines memory impairments due to AD and normal aging

$15 million pledged for creation of Johns Hopkins Greenberg Bladder Cancer Institute

Existing pharmaceutical drugs may offer effective therapies against MERS

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News